 Jordan Jacobelli
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 23 | 2024 | 1933 | 3.720 |
Why?
| | Cell Movement | 19 | 2024 | 944 | 3.310 |
Why?
| | Nonmuscle Myosin Type IIA | 5 | 2016 | 8 | 2.050 |
Why?
| | Actins | 7 | 2022 | 411 | 1.550 |
Why?
| | Microfilament Proteins | 2 | 2022 | 128 | 1.250 |
Why?
| | Cell Adhesion Molecules | 4 | 2022 | 173 | 1.240 |
Why?
| | Autoimmunity | 5 | 2021 | 862 | 1.220 |
Why?
| | Phosphoproteins | 2 | 2022 | 332 | 1.120 |
Why?
| | Lymphocyte Activation | 12 | 2022 | 1109 | 1.030 |
Why?
| | Transendothelial and Transepithelial Migration | 2 | 2017 | 30 | 0.970 |
Why?
| | Lymph Nodes | 4 | 2018 | 470 | 0.880 |
Why?
| | Actin-Related Protein 2-3 Complex | 2 | 2021 | 8 | 0.880 |
Why?
| | Cell Adhesion | 9 | 2017 | 452 | 0.760 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 857 | 0.710 |
Why?
| | Antigen-Presenting Cells | 7 | 2021 | 151 | 0.680 |
Why?
| | Molecular Imaging | 1 | 2018 | 55 | 0.560 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2018 | 135 | 0.540 |
Why?
| | Interleukin-4 | 1 | 2018 | 212 | 0.540 |
Why?
| | Cell Communication | 7 | 2014 | 300 | 0.540 |
Why?
| | Mice | 26 | 2024 | 16915 | 0.520 |
Why?
| | Immunological Synapses | 5 | 2022 | 16 | 0.510 |
Why?
| | Leukemia, Experimental | 1 | 2016 | 27 | 0.500 |
Why?
| | Animals | 34 | 2024 | 35307 | 0.470 |
Why?
| | Dendritic Cells | 6 | 2018 | 479 | 0.450 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2021 | 3628 | 0.450 |
Why?
| | Cell Nucleus | 2 | 2016 | 586 | 0.440 |
Why?
| | Peripheral Tolerance | 1 | 2013 | 15 | 0.410 |
Why?
| | Gene Expression | 1 | 2018 | 1466 | 0.400 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 278 | 0.400 |
Why?
| | Islets of Langerhans | 4 | 2021 | 789 | 0.400 |
Why?
| | Polymerization | 3 | 2022 | 123 | 0.390 |
Why?
| | Inflammation | 2 | 2020 | 2737 | 0.380 |
Why?
| | Myosin Type II | 3 | 2024 | 16 | 0.380 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5439 | 0.330 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2009 | 135 | 0.330 |
Why?
| | B-Lymphocytes | 4 | 2021 | 815 | 0.320 |
Why?
| | CD11c Antigen | 3 | 2019 | 41 | 0.300 |
Why?
| | Phagocytes | 2 | 2021 | 97 | 0.300 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2014 | 704 | 0.280 |
Why?
| | Mice, Knockout | 5 | 2020 | 2871 | 0.280 |
Why?
| | Signal Transduction | 12 | 2024 | 4926 | 0.280 |
Why?
| | Cytoskeletal Proteins | 2 | 2022 | 146 | 0.260 |
Why?
| | Antigens | 4 | 2021 | 356 | 0.260 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2015 | 363 | 0.250 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4057 | 0.240 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 36 | 0.230 |
Why?
| | Ephrin-B2 | 1 | 2024 | 50 | 0.230 |
Why?
| | Molecular Motor Proteins | 1 | 2004 | 35 | 0.220 |
Why?
| | Ovalbumin | 2 | 2015 | 178 | 0.220 |
Why?
| | Killer Cells, Natural | 6 | 2004 | 427 | 0.210 |
Why?
| | Brain | 1 | 2016 | 2669 | 0.210 |
Why?
| | Myosin Heavy Chains | 1 | 2004 | 170 | 0.200 |
Why?
| | Endothelial Cells | 2 | 2020 | 746 | 0.190 |
Why?
| | Lysophospholipids | 1 | 2022 | 72 | 0.190 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2021 | 44 | 0.180 |
Why?
| | Cell Line | 4 | 2020 | 2779 | 0.180 |
Why?
| | Immune Tolerance | 2 | 2021 | 355 | 0.180 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2117 | 0.180 |
Why?
| | Vaccines, Conjugate | 1 | 2021 | 63 | 0.180 |
Why?
| | Actin Cytoskeleton | 1 | 2021 | 104 | 0.170 |
Why?
| | Lymphatic System | 1 | 2020 | 11 | 0.170 |
Why?
| | Phosphorylation | 8 | 2014 | 1710 | 0.170 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2021 | 123 | 0.170 |
Why?
| | Pneumococcal Infections | 1 | 2021 | 111 | 0.170 |
Why?
| | Adaptive Immunity | 1 | 2021 | 161 | 0.170 |
Why?
| | Pneumococcal Vaccines | 1 | 2021 | 140 | 0.160 |
Why?
| | Streptococcus pneumoniae | 1 | 2021 | 159 | 0.160 |
Why?
| | Head and Neck Neoplasms | 1 | 2024 | 542 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2017 | 1056 | 0.150 |
Why?
| | Antigen Presentation | 2 | 2013 | 207 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 183 | 0.150 |
Why?
| | Germinal Center | 1 | 2018 | 57 | 0.140 |
Why?
| | Integrin alpha4 | 1 | 2017 | 7 | 0.140 |
Why?
| | Genes, Reporter | 1 | 2018 | 265 | 0.140 |
Why?
| | Cells, Cultured | 7 | 2016 | 4076 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 2 | 2012 | 412 | 0.130 |
Why?
| | Cellular Microenvironment | 2 | 2014 | 81 | 0.130 |
Why?
| | Chemotaxis | 1 | 2017 | 129 | 0.130 |
Why?
| | Microscopy | 1 | 2018 | 141 | 0.130 |
Why?
| | Nuclear Lamina | 1 | 2016 | 10 | 0.130 |
Why?
| | Mononuclear Phagocyte System | 1 | 2016 | 11 | 0.130 |
Why?
| | Protein-Tyrosine Kinases | 5 | 2003 | 432 | 0.130 |
Why?
| | Cytoskeleton | 3 | 2022 | 183 | 0.130 |
Why?
| | Spleen | 2 | 2015 | 506 | 0.130 |
Why?
| | Integrin beta1 | 3 | 2000 | 22 | 0.120 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2016 | 69 | 0.120 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2015 | 37 | 0.120 |
Why?
| | HIV-1 | 1 | 2021 | 837 | 0.120 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 2 | 2013 | 66 | 0.110 |
Why?
| | Humans | 23 | 2024 | 129248 | 0.110 |
Why?
| | Immunoblotting | 2 | 2016 | 305 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 742 | 0.100 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 109 | 0.100 |
Why?
| | Alum Compounds | 1 | 2013 | 22 | 0.100 |
Why?
| | Integrins | 3 | 2003 | 94 | 0.100 |
Why?
| | Software | 1 | 2018 | 606 | 0.100 |
Why?
| | Chemokines | 2 | 2006 | 226 | 0.100 |
Why?
| | Mice, Inbred NOD | 3 | 2021 | 588 | 0.100 |
Why?
| | Muramidase | 1 | 2012 | 77 | 0.100 |
Why?
| | Vaccination | 1 | 2021 | 1347 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 100 | 0.100 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 57 | 0.100 |
Why?
| | Flow Cytometry | 1 | 2016 | 1155 | 0.100 |
Why?
| | Autoantigens | 1 | 2014 | 419 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2013 | 221 | 0.090 |
Why?
| | Immune System | 1 | 2013 | 175 | 0.090 |
Why?
| | Immunoglobulin E | 1 | 2012 | 329 | 0.090 |
Why?
| | Tyrosine | 5 | 2004 | 223 | 0.090 |
Why?
| | Immunity, Cellular | 1 | 2013 | 265 | 0.090 |
Why?
| | Neutrophils | 1 | 2016 | 1207 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2018 | 1887 | 0.080 |
Why?
| | Interleukin-2 | 2 | 2004 | 437 | 0.080 |
Why?
| | Cell Surface Extensions | 1 | 2008 | 13 | 0.080 |
Why?
| | Cell Shape | 1 | 2008 | 54 | 0.080 |
Why?
| | GTP Phosphohydrolases | 1 | 2008 | 85 | 0.070 |
Why?
| | Transfection | 2 | 2009 | 915 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 305 | 0.070 |
Why?
| | Neoplasms | 1 | 2022 | 2449 | 0.070 |
Why?
| | Receptors, Chemokine | 2 | 2006 | 45 | 0.070 |
Why?
| | Cysteine Endopeptidases | 1 | 2007 | 68 | 0.070 |
Why?
| | Apoptosis | 1 | 2016 | 2498 | 0.070 |
Why?
| | Protozoan Proteins | 1 | 2007 | 75 | 0.070 |
Why?
| | Multigene Family | 1 | 2007 | 199 | 0.060 |
Why?
| | Protease Inhibitors | 1 | 2007 | 106 | 0.060 |
Why?
| | Receptors, IgG | 2 | 2004 | 73 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1396 | 0.060 |
Why?
| | Intracellular Fluid | 1 | 2005 | 27 | 0.060 |
Why?
| | Extracellular Fluid | 1 | 2005 | 31 | 0.060 |
Why?
| | Intercellular Junctions | 1 | 2005 | 39 | 0.060 |
Why?
| | Membrane Microdomains | 1 | 2005 | 33 | 0.060 |
Why?
| | Aging | 1 | 2015 | 1774 | 0.060 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2004 | 3 | 0.060 |
Why?
| | Epitopes | 1 | 2005 | 470 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2003 | 32 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2007 | 464 | 0.050 |
Why?
| | Interferon-gamma | 2 | 2014 | 772 | 0.050 |
Why?
| | Lung | 1 | 2016 | 3926 | 0.050 |
Why?
| | Female | 9 | 2021 | 68543 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 201 | 0.050 |
Why?
| | Male | 5 | 2021 | 63501 | 0.050 |
Why?
| | Vitronectin | 1 | 2002 | 5 | 0.050 |
Why?
| | Integrin beta Chains | 1 | 2002 | 8 | 0.050 |
Why?
| | Endothelium | 1 | 2003 | 121 | 0.050 |
Why?
| | Candida albicans | 1 | 2002 | 53 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 31 | 0.050 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 30 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 610 | 0.050 |
Why?
| | Chemokine CCL21 | 2 | 2015 | 14 | 0.050 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 27 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2000 | 311 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.050 |
Why?
| | Inducible T-Cell Co-Stimulator Protein | 1 | 2021 | 9 | 0.050 |
Why?
| | Immunogenicity, Vaccine | 1 | 2021 | 27 | 0.050 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 170 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 631 | 0.040 |
Why?
| | Antibodies, Bacterial | 1 | 2021 | 137 | 0.040 |
Why?
| | Proteins | 2 | 2004 | 941 | 0.040 |
Why?
| | Receptors, Fibronectin | 1 | 2000 | 4 | 0.040 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2000 | 54 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2000 | 220 | 0.040 |
Why?
| | Adenine | 1 | 2021 | 256 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2220 | 0.040 |
Why?
| | Piperazines | 1 | 2021 | 341 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2000 | 262 | 0.040 |
Why?
| | Carcinoma, Transitional Cell | 1 | 1999 | 59 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 1998 | 43 | 0.040 |
Why?
| | Enzyme Activation | 4 | 2002 | 812 | 0.040 |
Why?
| | Myeloid Cells | 1 | 2019 | 141 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 181 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2000 | 313 | 0.040 |
Why?
| | Focal Adhesion Kinase 2 | 3 | 2003 | 4 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3201 | 0.030 |
Why?
| | Cell Membrane | 2 | 2012 | 732 | 0.030 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1999 | 226 | 0.030 |
Why?
| | Lamin Type A | 1 | 2016 | 48 | 0.030 |
Why?
| | Mice, Nude | 2 | 2013 | 682 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 1998 | 399 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| | Cathepsins | 1 | 2015 | 24 | 0.030 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 2 | 2006 | 30 | 0.030 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2015 | 72 | 0.030 |
Why?
| | Cadaver | 1 | 2016 | 306 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 302 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3377 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.030 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2012 | 51 | 0.030 |
Why?
| | Cytokinesis | 1 | 2013 | 48 | 0.020 |
Why?
| | Cytokines | 1 | 2000 | 2013 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2012 | 218 | 0.020 |
Why?
| | Antigens, CD | 2 | 2006 | 489 | 0.020 |
Why?
| | Aerosols | 1 | 2012 | 170 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2630 | 0.020 |
Why?
| | Cell Separation | 1 | 2012 | 316 | 0.020 |
Why?
| | Lipid Bilayers | 1 | 2012 | 97 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 666 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 398 | 0.020 |
Why?
| | Fluorescence | 1 | 2010 | 155 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2008 | 137 | 0.020 |
Why?
| | Septins | 1 | 2008 | 43 | 0.020 |
Why?
| | Myosins | 1 | 2008 | 133 | 0.020 |
Why?
| | Autoantibodies | 1 | 2015 | 1467 | 0.020 |
Why?
| | Trypanosoma cruzi | 1 | 2007 | 25 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 450 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 10199 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2008 | 467 | 0.020 |
Why?
| | Chemokines, CC | 1 | 2006 | 33 | 0.020 |
Why?
| | Down-Regulation | 1 | 2008 | 636 | 0.020 |
Why?
| | Adult | 2 | 2021 | 35495 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2006 | 297 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2006 | 406 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2537 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 12388 | 0.010 |
Why?
| | Ligands | 1 | 2006 | 621 | 0.010 |
Why?
| | Wiskott-Aldrich Syndrome Protein | 1 | 2004 | 3 | 0.010 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2004 | 23 | 0.010 |
Why?
| | Chromosomes, Human, X | 1 | 2004 | 72 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 2003 | 7 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2004 | 299 | 0.010 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 37 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2056 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 2003 | 140 | 0.010 |
Why?
| | Integrin beta3 | 1 | 2002 | 6 | 0.010 |
Why?
| | Receptors, Vitronectin | 1 | 2002 | 9 | 0.010 |
Why?
| | Integrin alphaV | 1 | 2002 | 5 | 0.010 |
Why?
| | Proline | 1 | 2003 | 76 | 0.010 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2002 | 35 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2835 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2002 | 32 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2002 | 35 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 20303 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2004 | 1085 | 0.010 |
Why?
| | Thrombocytopenia | 1 | 2004 | 186 | 0.010 |
Why?
| | Antibodies | 1 | 2004 | 398 | 0.010 |
Why?
| | Antigens, Bacterial | 1 | 2002 | 119 | 0.010 |
Why?
| | Mutagenesis | 1 | 2002 | 181 | 0.010 |
Why?
| | Protein Binding | 1 | 2007 | 2120 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 2000 | 20 | 0.010 |
Why?
| | CD18 Antigens | 1 | 2000 | 26 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2000 | 41 | 0.010 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2000 | 7 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2000 | 90 | 0.010 |
Why?
| | K562 Cells | 1 | 2000 | 86 | 0.010 |
Why?
| | p21-Activated Kinases | 1 | 2000 | 15 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 31087 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 131 | 0.010 |
Why?
| | Fibronectins | 1 | 2000 | 123 | 0.010 |
Why?
| | Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 1998 | 12 | 0.010 |
Why?
| | Shc Signaling Adaptor Proteins | 1 | 1998 | 12 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1998 | 13 | 0.010 |
Why?
| | Retroviridae | 1 | 1999 | 99 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 275 | 0.010 |
Why?
| | Transplantation, Heterologous | 1 | 1999 | 192 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 205 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 184 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1999 | 312 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 1999 | 200 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 942 | 0.010 |
Why?
| | Genetic Therapy | 1 | 1999 | 288 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2002 | 901 | 0.010 |
Why?
| | Immunotherapy | 1 | 1999 | 592 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1416 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1999 | 2703 | 0.010 |
Why?
| | Infant | 1 | 2004 | 8975 | 0.010 |
Why?
| | Child, Preschool | 1 | 2004 | 10456 | 0.000 |
Why?
| | Child | 1 | 2004 | 20773 | 0.000 |
Why?
|
|
Jacobelli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|